BMB Reports : eISSN 1976-670X

Cited by CrossRef (9)

  1. Ying Yang, Wen-Jian Meng, Zi-Qiang Wang. Cancer Stem Cells and the Tumor Microenvironment in Gastric Cancer. Front. Oncol. 2022;11
  2. Jingyue Kang, Tonglin Sun, Yan Zhang. Immunotherapeutic progress and application of bispecific antibody in cancer. Front. Immunol. 2022;13
  3. Marlena Brzozowa-Zasada. The role of Notch ligand, Delta-like ligand 4 (DLL4), in cancer angiogenesis—implications for therapy. Eur Surg 2021;53:274
  4. Dong-Hoon Yeom, Yo-Seob Lee, Ilhwan Ryu, Sunju Lee, Byungje Sung, Han-Byul Lee, Dongin Kim, Jin-Hyung Ahn, Eunsin Ha, Yong-Soo Choi, Sang Hoon Lee, Weon-Kyoo You. ABL001, a Bispecific Antibody Targeting VEGF and DLL4, with Chemotherapy, Synergistically Inhibits Tumor Progression in Xenograft Models. IJMS 2020;22:241
  5. Frederick Allen, Ivan Maillard. Therapeutic Targeting of Notch Signaling: From Cancer to Inflammatory Disorders. Front. Cell Dev. Biol. 2021;9
  6. Xilong Wang, Jun Zhang, Yang Wang, Yangyun Wang, Wandong Yu, Guowei Shi. Potential biomarkers and the molecular mechanism associated with DLL4 during renal cell carcinoma progression. The American Journal of the Medical Sciences 2022;364:220
  7. Yan Dou, Jinghong Wang, Muhammad Zubair Asghar. Targeting Inhibition of Notch1 Signaling Pathway on the Study of Human Gastric Cancer Stem Cells with Chemosensitization. Computational Intelligence and Neuroscience 2022;2022:1
  8. Da Hyun Kim, Eun Ju Yang, JinAh Lee, Jeong Hyun Chang. Ginkgo biloba Leaf Extract Regulates Cell Proliferation and Gastric Cancer Cell Death. Biomed Sci Letters 2022;28:92
  9. Nadezda Zhdanovskaya, Mariarosaria Firrincieli, Sara Lazzari, Eleonora Pace, Pietro Scribani Rossi, Maria Pia Felli, Claudio Talora, Isabella Screpanti, Rocco Palermo. Targeting Notch to Maximize Chemotherapeutic Benefits: Rationale, Advanced Strategies, and Future Perspectives. Cancers 2021;13:5106